Epidural Analgesia Linked to Decline in Severe Maternal Morbidity
By Elana Gotkine HealthDay Reporter
FRIDAY, May 24, 2024 -- Epidural analgesia during labor is associated with a reduction in severe maternal morbidity (SMM), according to a study published online May 22 in The BMJ.
Rachel J. Kearns, M.D., from the Glasgow Royal Infirmary in Scotland, and colleagues conducted a population-based study to examine the effect of labor epidural on SMM in 567,216 women in labor at 24+0 to 42+6 weeks of gestation delivering vaginally or through unplanned cesarean section.
The researchers found that 22.0 percent of women had epidural analgesia during labor. Overall, SMM occurred in 2,412 women (4.3 per 1,000 births). Epidural analgesia was associated with significant decreases in SMM and SMM plus critical care admission (adjusted relative risks, 0.65 and 0.46, respectively) and with a nonsignificant decrease in respiratory morbidity. The risk reduction in SMM was larger for women with a medical indication for epidural analgesia (adjusted relative risk, 0.50). The reduction was more marked for women delivering preterm (adjusted relative risk, 0.53) than those delivering at term or postterm. In the whole cohort and among those with a medical indication for epidural analgesia, the reduced risk in SMM with epidural analgesia was increasingly noticeable as gestational age at birth decreased.
"These findings substantiate the current practice of recommending epidural analgesia during labor to women with known risk factors, underscores the importance of ensuring equitable access to such treatment, and highlights the importance of supporting women from diverse backgrounds to be able to make informed decisions relating to epidural analgesia during labor," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk
TUESDAY, May 20, 2025 -- Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published...
Buprenorphine for Opioid Use Disorder in Pregnancy Can Improve Outcomes
FRIDAY, May 2, 2025 -- For mothers with opioid use disorder (OUD), treatment with buprenorphine in pregnancy is associated with improved maternal and infant outcomes, according to...
USPSTF Recommends Counseling to Prevent Perinatal Depression
FRIDAY, April 25, 2025 -- The U.S. Preventive Services Task Force (USPSTF) recommends counseling for women at increased risk for perinatal depression (PND). This recommendation...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.